Pharmafile Logo
Pharmafocus logo
Advanced Search
egypt_india_locator

Egypt and India ties in pharmaceuticals encouraged

April 11, 2017
Manufacturing and Production Egypt, India, Sun Pharma

India and Egypt have been tentatively trying to build economic links for the last few years, with a particular focus …

News
opdivo_1_1

NICE turns down BMS’ Opdivo for head and neck cancer

April 11, 2017
Manufacturing and Production, Sales and Marketing BMS, NICE, opdivo

Bad news for Bristol-Myers Squibb as NICE chooses not to recommend its immunotherapy drug Opdivo (nivolumab) for use in head …

News

Bioverativ installs new EVP of R&D

April 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bioverativ

Bioverativ, a biotech company that develops therapies for rare blood disorders, announced the appointment of Tim Harris as Executive Vice …

Appointment
gilead-sciences

FDA approves first two antiviral hep C drugs for paediatric patients

April 10, 2017
Sales and Marketing FDA, harvoni, hepatitis C, sovaldi

The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi (sofosbuvir) …

News
human-ear-1462020301zmm

Virus fixes DNA mutations for possible hearing loss therapy

April 10, 2017
Research and Development, Sales and Marketing Ear, deafblindness, hearing loss, inner hair

Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …

News
actelion

EMA green lights Actelion’s drug after patient deaths scare

April 10, 2017
Sales and Marketing Actelion, Johnson & Johnson, Uptravi

The EMA has ruled that the five patient deaths that occurred in February of this year were not directly related …

News
roche_dark_0

Roche’s lung cancer drug beats Pfizer rival in study

April 10, 2017
Research and Development, Sales and Marketing Alecensa, Roche

Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing …

News

Fresenius confirms takeover talks with Akorn

April 10, 2017
Sales and Marketing Akorn, Fresenius

Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …

News
novartis_outside_1

Novartis takes on dry-eye market with drug in-licensing move

April 7, 2017
Medical Communications, Sales and Marketing Lubris, Novartis, dry eye

Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …

News
three_syringes

Old antibiotic nears new FDA approval after positive trials

April 7, 2017
Medical Communications, Research and Development Pfizer, Zavante, Zolyd, antibiotic

Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …

News
men-1179452_1920

Clinical trial shows yoga negates side-effects of prostate cancer treatment

April 7, 2017
Medical Communications prostate cancer, prostate treatment, yoga

Men who are treated for prostate cancer display side-effects of treatment by radiation that can often seriously disrupt their personal …

News
brain_cancer

Epicast: Brain Cancer – Epidemiology Forecast to 2024

April 7, 2017
Medical Communications, Research and Development brain cancer, pharmafile

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of …

News

Faubel takes over RFID specialist SIL

April 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Faubel, Nachfolger

The Melsungen printer Faubel & Co. Nachfolger GmbH, which mainly produces booklet labels and custom labels for the pharmaceutical industry, …

News
Press release
johnson_and_johnson_jj

J&J ordered to pay $5m over false marketing claims

April 6, 2017
Sales and Marketing J&J, JJ, lawsuit

Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …

News
dna-163466_960_720

CRISPR: An up close and personal take on precision medicine

April 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRISR, Precision Medicine

Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …

Feature
sanjiv

Relay Therapeutics appoints Allergan CSO to CEO position

April 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay

Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …

Appointment
mosquito

Takeda completes enrollment for largest-ever study of dengue vaccine

April 6, 2017
Research and Development Takeda, clinical trial, dengue

Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …

News
shutterstock_292920209

Care Quality Commission targets website which gave prescriptions in 17 seconds

April 6, 2017
Medical Communications, Sales and Marketing Care Quality Commission, prescription

The Care Quality Commission (CQC), England’s health and social care service regulator, has identified four online prescription medicine vendors engaging …

News
depression

Ketamine found to offer hope as last-resort treatment for depression

April 6, 2017
Research and Development Ketamine, University of Oxford

Researchers from the University of Oxford have conducted a six-year study looking into the potential therapeutic effects of ketamine as …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026